|
⚲
|
| Keyboard |
| Lichti Braeden
✚
|
|
|---|---|
| CIK # | 0001982476 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001982476] | |
| 4 | [0001982476] | |
| SC 13D | [0001982476] | |
| SC 13G | [0001982476] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Braeden Lichti | |
| PMGC Holdings Inc | |
| Aquabounty Technologies Inc | |
| Ritter Pharmaceuticals Inc | |
| Marizyme Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PMGC Holdings Inc ELAB
Series B Preferred Stock
|
2025-03-26 | Grant | 3,336,437 | $0.00 | |
|
Marizyme Inc MRZM
Common stock
|
2023-12-21 | Conversion | 3,815,294 | $0.10 | 381,529 |
|
Marizyme Inc MRZM
10% Secured Convertible Promissory Note · derivative
|
2023-12-21 | Conversion | 2 | $0.00 | |
|
Marizyme Inc MRZM
Common shares
|
2023-08-29 | Buy | 105,000 | $0.17 | 17,850 |
|
Marizyme Inc MRZM
Common shares
|
2023-07-07 | Buy | 97,000 | $0.10 | 9,700 |
|
Marizyme Inc MRZM
Common shares
|
2023-06-29 | Buy | 106,327 | $0.09 | 9,569 |